<DOC>
	<DOCNO>NCT00153153</DOCNO>
	<brief_summary>To evaluate safety efficacy extend use polyethyleneglycol3350 laxative compare placebo constipated patient .</brief_summary>
	<brief_title>Extended Use Polyethyleneglycol3350 Laxative Constipated Patients</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Laxatives</mesh_term>
	<mesh_term>Polyethylene glycol 3350</mesh_term>
	<criteria>Male female outpatient least 18 year age Constipated accord ROME I criteria On average , few 3 satisfactory BMs per week observation period If female childbearing potential , patient must surgically sterilize use oral contraceptive , depot contraceptive , intrauterine device , testify monogamous vasectomized partner , practice abstinence continue duration study Are otherwise good health , judge physical examination In investigator 's judgment , patient mentally competent sign instrument inform consent Patients heme positive stool screening . Patients heme positive stool attribute hemorrhoid anal fissure eligible inclusion . Patients hypo hyperthyroidism determine history , screen TSH result . Patients know suspected perforation obstruction . History gastric retention , inflammatory bowel disease , bowel resection , colostomy . Patients known history organic cause constipation . Patients meet ROME definition Irritable Bowel Syndrome Patients currently take follow medication know effect bowel habit : Antidiarrheals Antacids contain magnesium aluminum salt Anticholinergics Antispasmodic agent Erythromycin macrolides Octreotide Lotronex , Zofran , 5HT3 antagonist Zelnorm , 5HT4 agonist Opiods/narcotic analgesic Prokinetics Serotonin reuptake inhibitor tricyclic antidepressant Calcium antagonist Patients breastfeed , pregnant , intend become pregnant study . Female patient childbearing potential refuse pregnancy test . Patients know allergy corn polyethylene glycol . Patients , opinion investigator , include study reason , include inability follow study procedure . Patients , within past 30 day participate investigational clinical study Patients undergone colonoscopy within 30 day begin 14 day observation period . Patients currently take , previously treat polyethyleneglycol3350</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>